Literature DB >> 17407977

Cancers in infancy: percent distribution and incidence rates.

Chao-Ping Yang1, Iou-Jih Hung, Tang-Her Jaing, Wan-Hui Chang.   

Abstract

Cancer occurring in infants often has clinical and biological properties that are different from those of the same histologic type of cancer occurring in older children. The histologic distribution of cancers in infants and that in older children are also different. We collected infant cases diagnosed as having cancer from the database of the Cancer Registry in our Medical Center between 1995 and 2004. One hundred and twenty infants (66 males and 54 females), including 17 neonates, were diagnosed with cancer over this 10-year period. The top five cancer subtypes were: leukemia in 34 infants (28.3%), retinoblastoma in 19 (15.8%), neuroblastoma in 16 (13.3%), germ cell tumor in 15 (12.5%), and brain tumor in 14 (11.7%). The overall disease-free survival rate was 54. 2% (65/120) with a median follow-up duration of 7.6 years for the survivors. From the cancer registry in our hospital during the same period, 1995-2004, infant cases accounted for 9.5% of the total 1,269 children with cancer diagnosed at the age younger than 15 years. The percent distribution of the major types of cancer was different in the infant and the childhood group. According to the Taiwan Pediatric Oncology Group's data analysis, the infant cancer incidence rate in Taiwan is 207.6 per million infants for years 1995-2004. Our study confirmed that the prognosis is very poor for infant leukemia and rhabdoid tumor, while that is good for embryonal tumors and germ cell tumors occurring in the infancy.

Entities:  

Mesh:

Year:  2006        PMID: 17407977

Source DB:  PubMed          Journal:  Acta Paediatr Taiwan        ISSN: 1608-8115


  7 in total

Review 1.  Neonatal tumours.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2013-10-31       Impact factor: 1.827

2.  Compliance in retinoblastoma.

Authors:  Sameer Bakhshi; Shikha Gupta; Varun Gogia; Yaddanapuddi Ravindranath
Journal:  Indian J Pediatr       Date:  2010-03-19       Impact factor: 1.967

3.  Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

Authors:  Renée L Mulder; Dorine Bresters; Malon Van den Hof; Bart Gp Koot; Sharon M Castellino; Yoon Kong K Loke; Piet N Post; Aleida Postma; László P Szőnyi; Gill A Levitt; Edit Bardi; Roderick Skinner; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2019-04-15

4.  Ocular prostheses in the last century: a retrospective analysis of 8018 patients.

Authors:  A Modugno; F Mantelli; S Sposato; C Moretti; A Lambiase; S Bonini
Journal:  Eye (Lond)       Date:  2013-05-17       Impact factor: 3.775

5.  Retinoblastoma in the democratic republic of congo: 20-year review from a tertiary hospital in kinshasa.

Authors:  Aimé Kazadi Lukusa; Michel Ntetani Aloni; Bertin Kadima-Tshimanga; Moïse Mvitu-Muaka; Jean Lambert Gini Ehungu; René Ngiyulu; Pépé Ekulu Mfutu; Aléine Budiongo Nzazi
Journal:  J Cancer Epidemiol       Date:  2012-04-26

6.  JARID1B Expression Plays a Critical Role in Chemoresistance and Stem Cell-Like Phenotype of Neuroblastoma Cells.

Authors:  Yung-Ting Kuo; Yen-Lin Liu; Bamodu Oluwaseun Adebayo; Ping-Hsiao Shih; Wei-Hwa Lee; Liang-Shun Wang; Yung-Feng Liao; Wen-Ming Hsu; Chi-Tai Yeh; Chien-Min Lin
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

7.  Outcome of Children with Wilms' Tumor in Developing Countries.

Authors:  Gholamreza Bahoush; Elahe Saeedi
Journal:  J Med Life       Date:  2020 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.